What is the primary objective of **SAFe**?

**The primary objective of SAFe is to scale Lean-Agile practices across large enterprises to achieve Business Agility through alignment, collaboration, and value delivery among hundreds of teams.** SAFe integrates 10 immutable Lean-Agile principles, such as taking an economic view and organizing around value, with seven core competencies like Lean-Agile Leadership and Continuous Learning Culture. It structures delivery via Agile Release Trains (ARTs) of 50-125 members operating in 8-12 week Program Increments (PIs), enabling faster time-to-market, improved quality, and employee engagement in software and IT operations.

Who is legally or professionally required to comply with **SAFe**?

**No organization is legally required to comply with SAFe, as it is a voluntary framework for enterprise agility rather than a regulatory standard.** Professionally, large enterprises with 50+ teams in software development, IT operations, or regulated sectors like finance and healthcare adopt SAFe to coordinate ARTs, manage dependencies, and integrate compliance (e.g., GDPR, SOC 2) via 'trust but verify' practices. Over 20,000 enterprises and 1 million certified professionals use it for scaling beyond single-team Agile.

Does **SAFe** require an external audit or third-party certification?

**SAFe does not require external audits or third-party certification, relying instead on internal assessments like Inspect and Adapt workshops.** Organizations pursue voluntary SAFe certifications (e.g., SAFe Agilist, RTE) through Scaled Agile's academy for roles and competencies. Success is measured via PI metrics, flow optimization, and maturity models, with tools like Jira Align supporting self-audits in ARTs and portfolios.

How often should an assessment for **SAFe** be performed?

**SAFe assessments should be performed at the end of each 8-12 week Program Increment (PI) during Inspect and Adapt workshops.** These events review PI objectives, metrics like velocity and flow, and risks via ROAM analysis, fostering continuous improvement. Additional maturity assessments occur pre-implementation and quarterly at portfolio levels to evaluate competencies and value stream alignment.

What are the consequences of non-compliance with **SAFe**?

**Non-compliance with SAFe carries no legal penalties, but results in business risks like siloed teams, delayed delivery, and missed agility gains.** Poor implementation leads to dependency chaos, 30-70% transformation failure rates, and suboptimal outcomes such as extended time-to-market or quality defects, as seen in critiques of hierarchy without tailoring. Organizations face internal opportunity costs without ART synchronization and PI cadence.

Can **SAFe** be mapped to other international frameworks?

**Yes, SAFe can be mapped to other frameworks like Scrum, Kanban, LeSS, and DevOps for hybrid implementations.** Its Essential configuration aligns with team-level Scrum (2-week iterations), while Large Solution and Portfolio levels extend to complex scaling like LeSS. Tools like Jira Align and Vanta facilitate mappings, embedding practices such as DevSecOps pipelines and compliance for seamless integration without diluting SAFe's 10 principles.

What is the first step to begin implementing **SAFe**?

**The first step to implement SAFe is to conduct Leading SAFe training for executives and form a Lean-Agile Center of Excellence (LACE).** Follow the Implementation Roadmap: train leaders in Lean-Agile principles, perform value stream mapping to identify ARTs, and assess organizational readiness. This phased approach, starting with Essential SAFe, ensures buy-in and prevents pitfalls like 'SAFe washing.'

What is the primary objective of **FDA 21 CFR Part 11**?

**The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the Agency considers electronic records and electronic signatures trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper (§11.1(a)).** This equivalency enables electronic methods while ensuring authenticity, integrity, availability, and non-repudiation through controls for closed (§11.10) and open (§11.30) systems, plus electronic signature requirements (§§11.50–11.300).

Who is legally or professionally required to comply with **FDA 21 CFR Part 11**?

**FDA 21 CFR Part 11 applies to organizations using electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, or electronic records/signatures relied upon for regulated activities (§11.1(b)).** Scope includes pharmaceutical, biotech, medical device, and related firms maintaining predicate-required records electronically in lieu of paper, or submitting accepted electronic records to FDA; paper-reliant systems are generally excluded per 2003 guidance.

Does **FDA 21 CFR Part 11** require an external audit or third-party certification?

**No, FDA 21 CFR Part 11 does not require external audits or third-party certification.** Compliance is demonstrated through internal validation, SOPs, training records, and inspection readiness (§11.1(e)), with systems, controls, and documentation available for FDA review; predicate rules remain enforceable regardless of enforcement discretion on certain Part 11 elements.

How often should an assessment for **FDA 21 CFR Part 11** be performed?

**FDA 21 CFR Part 11 does not prescribe a fixed frequency for assessments; organizations must perform risk-based periodic reviews tied to change control, system lifecycle, and predicate rule requirements.** The 2003 guidance supports ongoing evaluation via validation maintenance, audit trail reviews, access audits, and reassessments during changes to ensure continued fitness for use.

What are the consequences of non-compliance with **FDA 21 CFR Part 11**?

**Non-compliance with FDA 21 CFR Part 11 can result in FDA enforcement actions including Form 483 observations, warning letters, product holds, recalls, and fines under predicate rules.** Even with enforcement discretion on validation/audit trails, failures in enforced controls (access, signatures) or predicate violations lead to regulatory actions impacting product quality and operations.

Can **FDA 21 CFR Part 11** be mapped to other international frameworks?

**FDA 21 CFR Part 11 can align with other frameworks through shared principles like data integrity and controls, though no formal mapping is specified in the regulation or 2003 guidance.** Organizations often harmonize via risk-based approaches for equivalency in electronic records/signatures.

What is the first step to begin implementing **FDA 21 CFR Part 11**?

**The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions.** Document scope decisions (e.g., in SOPs) per 2003 guidance to determine Part 11 records, distinguishing closed/open systems and prioritizing high-risk controls.

SAFe vs FDA 21 CFR Part 11

Standards Comparison

SAFe

Voluntary

2023

Framework scaling Lean-Agile practices across large enterprises

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for trustworthy electronic records and signatures

Quick Verdict

SAFe scales Agile for enterprise software delivery, while FDA 21 CFR Part 11 mandates controls for trustworthy electronic records in life sciences. Companies adopt SAFe for agility and speed; Part 11 for regulatory compliance and data integrity.

Agile Scaling

SAFe

Scaled Agile Framework (SAFe) 6.0

Cost

€€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Organizes 50-125 people into Agile Release Trains (ARTs)
Delivers value via 8-12 week Program Increments (PIs)
Foundational 10 immutable Lean-Agile principles
Seven interconnected core competencies for Business Agility
Scalable configurations from Essential to Full SAFe

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11 Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Risk-based controls for closed and open systems
Secure time-stamped audit trails for actions
Multi-component electronic signatures with non-repudiation
System validation for accuracy and integrity
Access authority and device checks enforced

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

SAFe Details

What It Is

Scaled Agile Framework (SAFe) 6.0 is a comprehensive knowledge base of organizational and workflow patterns for scaling Lean-Agile practices across enterprises. It integrates Agile, Lean, systems thinking, and DevOps to enable Business Agility in large-scale software and IT environments, focusing on alignment, flow, and value delivery.

Key Components

**Agile Release Trains (ARTs)50-125 cross-functional teams delivering via Program Increments (PIs).
10 immutable Lean-Agile principles and 7 core competencies (e.g., Lean-Agile Leadership, Continuous Learning Culture).
Structures: PI Planning, Inspect & Adapt, artifacts like Roadmaps and PI Objectives.
Scalable configurations: Essential, Large Solution, Portfolio, Full SAFe. No formal certification for organizations, but individual role-based certifications (e.g., RTE, Agilist).

Why Organizations Use It

Drives faster time-to-market (20-50%), productivity gains (30-75%), quality improvements, and employee engagement. Addresses enterprise challenges like silos, dependencies, and compliance (GDPR, SOC 2). Builds strategic alignment via dual operating system, enhancing competitiveness and risk management.

Implementation Overview

Phased roadmap: value stream mapping, leadership training (SAFe Agilist), ART launches, SPC coaching. Applies to large enterprises in software/IT, regulated industries. Demands cultural shift, tools (Jira Align, Vanta), ongoing Inspect & Adapt; 18-24 months typical.

FDA 21 CFR Part 11 Details

What It Is

21 CFR Part 11 is the FDA regulation setting criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It governs FDA-regulated industries using electronic systems instead of paper for predicate-rule records. The risk-based approach narrows scope per 2003 guidance, focusing on reliance and enforcement discretion for some controls.

Key Components

**SubpartsGeneral Provisions, Electronic Records (closed/open systems), Electronic Signatures.
Controls include validation, audit trails, access limits, operational/authority/device checks, training, policies.
Built on data integrity principles like ALCOA+; compliance via CSV, no formal certification.

Why Organizations Use It

Mandatory for electronic reliance in regulated activities to avoid enforcement.
Ensures data integrity, streamlines inspections, enables digital transformation.
Mitigates risks, boosts efficiency, builds regulator and stakeholder trust.

Implementation Overview

Phased: scoping, gap analysis, risk assessment, CSV (IQ/OQ/PQ), SOPs, training, monitoring.
Applies to life sciences firms globally; cross-functional IT/QA effort.
Readiness via inspections, mock audits; ongoing change control.

Key Differences

Aspect	SAFe	FDA 21 CFR Part 11
Scope	Scaling Agile for enterprise software/IT	Electronic records/signatures trustworthiness
Industry	Software, IT ops, all enterprises globally	Life sciences, pharma, devices (US FDA-regulated)
Nature	Voluntary scaling framework	Mandatory US federal regulation
Testing	PI planning, Inspect & Adapt workshops	Risk-based system validation (IQ/OQ/PQ)
Penalties	No legal penalties, implementation failure	Warning letters, fines, product holds

Scope

SAFe

Scaling Agile for enterprise software/IT

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness

Industry

SAFe

Software, IT ops, all enterprises globally

FDA 21 CFR Part 11

Life sciences, pharma, devices (US FDA-regulated)

Nature

SAFe

Voluntary scaling framework

FDA 21 CFR Part 11

Mandatory US federal regulation

Testing

SAFe

PI planning, Inspect & Adapt workshops

FDA 21 CFR Part 11

Risk-based system validation (IQ/OQ/PQ)

Penalties

SAFe

No legal penalties, implementation failure

FDA 21 CFR Part 11

Warning letters, fines, product holds

Frequently Asked Questions

Common questions about SAFe and FDA 21 CFR Part 11

SAFe FAQ

FDA 21 CFR Part 11 FAQ

You Might also be Interested in These Articles...

DORA Third-Party Risk Management: A Consultant’s Guide to Mapping Critical ICT Service Providers in 2026

Navigate DORA's complex third-party risk pillar. Step-by-step consultant guide to identify critical ICT providers, remediate Article 30 contracts, and build the

SOC 2 Audit Survival Guide: 10 Red Flags Auditors Flag and Model Answers for Walkthroughs

Master SOC 2 Type 2 audits with our guide: 10 red flags like incomplete logs/vendor gaps, model walkthrough answers, psychology tips. Pass first-time with <5% e

Why the SEC Stepped In: The Investor-Driven Push for Cybersecurity Transparency

Discover why the SEC's 2023 cybersecurity rules treat cyber risks as material financial threats. Explore the 'stick and carrot' approach for standardized disclo

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Check out these other Gradum.io Standards Comparison Pages

EMAS vs EU AI Act

EMAS vs EU AI Act: Compare voluntary eco-management with risk-based AI rules. Uncover compliance differences, obligations & strategies for EU business success.

BRC vs ISO 56002

Compare BRC vs ISO 56002: Food safety certification meets innovation management. Key differences, structures, benefits & implementation for compliance, quality & growth. Dive in now!

ENERGY STAR vs ISO 41001

Compare ENERGY STAR vs ISO 41001: US govt energy labeling/benchmarking for products, buildings & plants vs global FM system standard. Cut costs, emissions—boost efficiency. Discover the best fit now.

SAFe

FDA 21 CFR Part 11

Quick Verdict

SAFe

Key Features

FDA 21 CFR Part 11

Key Features

Detailed Analysis

SAFe Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

FDA 21 CFR Part 11 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

Key Differences

Scope

Industry

Nature

Testing

Penalties

Frequently Asked Questions

SAFe FAQ

What is the primary objective of SAFe?

Who is legally or professionally required to comply with SAFe?

Does SAFe require an external audit or third-party certification?

How often should an assessment for SAFe be performed?

What are the consequences of non-compliance with SAFe?

Can SAFe be mapped to other international frameworks?

What is the first step to begin implementing SAFe?

FDA 21 CFR Part 11 FAQ

What is the primary objective of FDA 21 CFR Part 11?

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

How often should an assessment for FDA 21 CFR Part 11 be performed?

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

What is the first step to begin implementing FDA 21 CFR Part 11?

You Might also be Interested in These Articles...

DORA Third-Party Risk Management: A Consultant’s Guide to Mapping Critical ICT Service Providers in 2026

SOC 2 Audit Survival Guide: 10 Red Flags Auditors Flag and Model Answers for Walkthroughs

Why the SEC Stepped In: The Investor-Driven Push for Cybersecurity Transparency

Run Maturity Assessments with GRADUM

Check out these other Gradum.io Standards Comparison Pages

EMAS vs EU AI Act

BRC vs ISO 56002

ENERGY STAR vs ISO 41001